Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used

BMJ. 1996 Mar 16;312(7032):704; author reply 704-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Drug Therapy, Combination
  • Humans
  • Levodopa / adverse effects*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / mortality*
  • Research Design
  • Selegiline / adverse effects*

Substances

  • Antiparkinson Agents
  • Selegiline
  • Levodopa